KOSDAQ/950160 (KOSDAQ/950160)

KOSDAQ: KOSDAQ/950160 · KRW

₩14,600

-159.40 (-1.1%)· Recorded snapshot

Market cap	1.2T
Revenue (ttm)	4.8B
Net income (ttm)	-181B
EPS (ttm)	-₩2,163
Shares out	85M
Volume	309,582
Beta	-0.33

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.8B
Net income (ttm): -181B
EPS (ttm): -₩2,163
Market cap: 1.2T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 7P50 11.1P75 20.3

Trailing P/En/a

P25 7.2P50 12.6P75 23.6

ROE-113.1

P25 -16.3P50 0.9P75 9.4

ROIC-7

P25 -9.5P50 1.6P75 7.2

Benchmarks · 1M

All KOSDAQ/950160 indicators

Market & fundamental data

Available fields

177

Groups with data

Currency

KRW

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	KRW
Country	United States
Country code	KR
Employees	29
Enterprise value	KRW 1.2T
Exchange	KOSDAQ
Financial currency	KRW
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1999
Industry	Biotechnology
Is primary listing	Yes
ISIN number	KR8840120008
Last refreshed	2026-10-28
Market cap	KRW 1.2T
Price	KRW 14,600.00
Price currency	KRW
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	kosdaq/950160
Website	https://www.tissuegene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-14.82%
EV/Sales	251.85x
FCF / EV yield	-1.5%
FCF yield	-1.46%
Industry forward P/E	31.07x
Industry P/E	52.84x
P/B ratio	6.08x
P/S ratio	258.63x
Price / tangible book value	6.09x
Sector forward P/E	24.78x
Sector P/E	49.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	11.61%
Operating margin	-501.03%
Pretax margin	-3,772.84%
Profit per employee	KRW -6.2B
Profitable quarters	1
Revenue per employee	KRW 165.4M
ROA	-3.79%
ROA (5Y)	-15.65%
ROCE	-11.54%
ROE	-113.08%
ROE (5Y)	-70.47%
ROIC	-7.02%
SBC / revenue	3.93%
Tax / revenue	-0%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	-10.88%
Gross profit growth (Q)	-45.02%
Gross profit growth 3Y	-48.07%
Gross profit growth 5Y	-0.23%
Net income growth quarters	1
Net income growth years	0
Revenue growth	-12.58%
Revenue growth (Q)	-39.02%
Revenue growth (QoQ)	-42.65%
Revenue growth 3Y	-7.41%
Revenue growth 5Y	5.23%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	KRW -701.6M
Depreciation and amortization	KRW 904.7M
EBIT	KRW -24B
EBITDA	KRW -23.1B
EPS	KRW -2,163.19
FCF per share	KRW -212.74
Financing cash flow	KRW 182.1B
Free cash flow	KRW -18.1B
Free cash flow minus SBC	KRW -18.3B
Gross profit	KRW 556.9M
Income taxes	KRW -68,000
Investing cash flow	KRW -116.4B
Net borrowing	KRW 122.6B
Net cash flow	KRW 47.8B
Net income	KRW -181B
Operating cash flow minus SBC	KRW -17.6B
Operating income	KRW -24B
Revenue	KRW 4.8B
Stock-based compensation	KRW 188.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	9.51
Book value per share	KRW 2,403.39
Debt / equity	0.31
Interest coverage	-228.47
Long-term assets	KRW 411.8B
Long-term liabilities	KRW 4.1B
Net cash (debt)	KRW 32.6B
Net cash / market cap	2.63%
Net debt / equity	-0.16
Piotroski F-Score	3
Property, plant and equipment	KRW 5.9B
Shareholders' equity	KRW 204.1B
Tangible book value	KRW 203.8B
Tangible book value per share	KRW 2,400.11
Total assets	KRW 513.2B
Total cash	KRW 95.3B
Total debt	KRW 62.7B
Total liabilities	KRW 309.1B
WACC	2.32%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.01
Current assets	KRW 101.4B
Current liabilities	KRW 305B
Current ratio	0.33
Inventory turnover	53.47
Net working capital	KRW -240B
Quick ratio	0.31
Working capital	KRW -203.6B
Working capital turnover	-0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-5.46%
Shareholder yield	-5.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	KRW 64,025.00
1D price change	-1.08%
1M price change	-7.59%
1M total return	-7.59%
1W price change	-9.32%
1W total return	-9.32%
1Y price change	-69.03%
1Y return CAGR	-69.06%
1Y total return	-69.03%
20-day SMA	KRW 15,304.50
200-day SMA	KRW 70,792.25
3M price change	-8.23%
3M total return	-8.23%
3Y price change	72.99%
3Y return CAGR	20.04%
3Y total return	72.99%
50-day SMA	KRW 17,392.20
50-day SMA vs 200-day SMA	50under200
52-week high	KRW 149,000.00
52-week high date	2026-05-12
52-week low	KRW 11,470.00
52-week low date	2026-07-30
6M price change	-85.83%
6M total return	-85.83%
All-time high	KRW 149,000.00
All-time high date	2026-05-12
All-time low	KRW 7,710.00
All-time low date	2023-10-27
Average true range (ATR)	KRW 1,151.98
Average volume	463K
Beta (1Y)	1.22
Beta (2Y)	0.9
Beta (5Y)	-0.33
Change from 52-week high	-90.2%
Change from 52-week low	27.29%
Change from all-time high	-90.2%
Change from all-time low	89.36%
Change from open	-2.01%
Day's gap	0.95%
Dollar volume	KRW 4.5B
High price	KRW 15,340.00
Low price	KRW 14,490.00
Monthly RSI	36.62
Open price	KRW 14,900.00
Position in 52-week range	12.94%
Previous close	KRW 14,760.00
Price vs 150-day SMA	-77.2%
Price vs 20-day SMA	-4.6%
Price vs 200-day SMA	-79.38%
Price vs 50-day SMA	-16.05%
Relative volume	0.67
RSI	40.07
Sharpe ratio	-0.43
Sharpe ratio (3Y)	0.58
Sortino ratio	-0.52
Sortino ratio (3Y)	0.93
Volume	309.6K
Weekly RSI	30.79
YTD price change	-81.66%
YTD total return	-81.66%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18.2M
Shares change (QoQ)	1.65%
Shares change (YoY)	5.46%
Shares held by insiders	17.91%
Shares held by institutions	0.63%
Shares outstanding	85M

Deeper analysis on KOSDAQ/950160

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this KOSDAQ/950160 report

Is a complete KOSDAQ/950160 research report available?

No complete published report is available for kosdaq/950160 (KOSDAQ/950160) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

KOSDAQ/950160 (KOSDAQ/950160)

Price

Financial snapshot

Fair-value bridge

Latest news · KOSDAQ/950160

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KOSDAQ/950160 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on KOSDAQ/950160

Frequently asked questions